Request Free Sample
Osteoporosis Drugs Market Review
The global osteoporosis drugs market was valued at an $8,835.4 million in 2015, and is expected to grow at a CAGR of 3.8% during 2016 – 2022, to reach $11,482.1 million by 2022. The market will be growing at a significant rate due to increasing healthcare expenditure and increasing awareness of osteoporotic care. In addition, increasing prevalence of osteoporosis in post-menopausal women, and increasing research and development(R&D) investment in drug discovery and development will also be driving the growth of the osteoporosis drugs industry.
 
GLOBAL OSTEOPOROSIS DRUG MARKET BY DRUG TYPE $M (2012–2022)
 
In terms of drug type, the osteoporosis drugs market has been segmented into bisphosphonates, parathyroid hormone therapy, SERM, rank ligand inhibitor, calcitonin, and others.

Source: Click here